Tredegar Corporation 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Tredegar Corporation for the period ended June 30, 1999. The company operates in manufacturing (Film Products, Aluminum Extrusions) and technology sectors. The reporting period is heavily influenced by significant acquisitions, most notably the purchase of Exxon Chemical Company's plastic films business ("Exxon Films") on May 17, 1999, for approximately $203.9 million.
Key Financial Metrics
Revenue and Profit (Six Months Ended June 30, 1999):
- Net Sales: $374.4 million (up from $326.6 million in 1998).
- Net Income: $25.5 million (down from $32.5 million in 1998).
- Diluted Earnings Per Share (EPS): $0.65 (down from $0.84 in 1998).
- Gross Profit Margin: 21.4% (up from 21.1% in 1998).
- EBITDA: $61.1 million (16.3% of net sales).
Cash Flow and Liquidity:
- Cash and Cash Equivalents: $19.9 million (down from $25.4 million at year-end 1998).
- Operating Cash Flow: $52.4 million provided by operating activities.
- Investing Cash Flow: $266.4 million used, primarily for acquisitions ($213.7 million) and capital expenditures ($23.2 million).
- Financing Cash Flow: $208.5 million provided, driven by a $209 million net increase in borrowings.
Debt and Balance Sheet:
- Total Assets: $705.7 million (up from $457.2 million).
- Total Liabilities: $369.5 million (up from $146.9 million).
- Long-Term Debt: $234.0 million (up from $25.0 million). This includes $214 million in floating-rate borrowings under a $275 million revolving credit facility.
- Debt-to-Capitalization: 41%.
Material Changes vs. Prior Period
Acquisitions: The primary driver of financial changes was the acquisition of Exxon Films, which added significant revenue and assets but also increased debt and amortization. Other acquisitions included Therics Inc. (technology) and Exal Aluminum Inc.
Profitability: While net sales increased due to acquisitions, net income declined. On a pro forma basis (assuming acquisitions occurred at the start of 1998), net sales would have declined by 1% due to lower volume in Film Products and lower selling prices reflecting reduced resin and aluminum costs.
Unusual Items: The company recorded $4.6 million in unusual items for the six months ended June 30, 1999. This includes a $3.5 million nonrecurring charge for the write-off of in-process research and development related to the Therics acquisition and $1.2 million in equipment writedowns.
Segment Performance:
- Aluminum Extrusions: Profits increased 14% due to higher volume and the Exal acquisition.
- Film Products: Profits from ongoing operations were up 6% due to Exxon Films; however, excluding the acquisition, profits declined due to higher product development costs and start-up expenses in Hungary.
- Technology: Losses increased due to the inclusion of Therics results and venture capital investment writedowns.
Guidance, Outlook, and Risks
Management Commentary: Management expects annual ongoing synergy benefits from the Exxon Films integration to range from $7 million to $9 million by 2001. The company is reviewing loan-financing alternatives to restore the available balance under its credit facility.
Risks and Contingencies:
- Year 2000 Compliance: The company is remediating systems for the acquired Exxon Films business, with an estimated cost of $1.9 million to be completed by the end of 1999. While internal systems are largely compliant, failure of major customers or suppliers to be compliant could have a material adverse effect.
- Market Risk: Exposure to volatility in interest rates, resin prices, aluminum ingot/scrap prices, and foreign currencies. The company uses hedging strategies for aluminum price volatility.
- Venture Capital: Investments in early-stage technology companies are illiquid and subject to market volatility. Most liquidation opportunities are not expected for several years.
- Debt Levels: The company has significantly increased leverage to fund acquisitions, with 41% of total capitalization in debt.
Investor Verification Checklist
- Verify the integration progress and realized synergies from the Exxon Films acquisition against the projected $7-$9 million annual benefit.
- Monitor the company's ability to service its increased debt load ($234 million) and the status of refinancing efforts to restore credit facility availability.
- Assess the impact of the $3.5 million in-process R&D write-off on the long-term viability of the Therics technology.
- Review the operational status of the new plant in Hungary and its impact on Film Products margins.
- Confirm the completion of Year 2000 remediation for the Exxon Films systems by the end of 1999.